Page results
-
Doctors at UCLH and University College London (UCL) have developed a digital decision-making aid, MENO.pause, to help clinicians manage menopause symptoms in the best way for individual patients’ health conditions.
-
Our vaccination centre at the Business Design Centre, Islington, closed on Monday 10 January.
-
Thrombotic Thrombocytopenia Purpura (TTP) is a rare disorder of the blood coagulation system.
-
A multi-disciplinary team involving UCLH and UCL has developed a way to monitor the progression of movement disorders using motion capture technology and AI.
-
Ensuring that UCLH staff understand the urgency of the climate crisis and support our net zero programme is crucial if we want to be successful in reaching our goal of net zero carbon emissions by 2031. Our patients must be kept informed of changes and we must work closely with other NHS organisations, including NHS England, if we are to deliver a successful programme. This page documents our progress to date.
-
UCLH needs to reduce the amount we consume per patient, re-use and re-manufacture what we can and ensure that what we do use has minimal environmental impact. We also need to ensure our suppliers match our environmental ambitions. This page explores our progress so far.
-
Delivering vital interventions, medicines and all other healthcare services are responsible for a major part of the NHS’s carbon emissions. We need to redesign our services to reduce their environmental impact, whilst maintaining the highest standards of care delivery. This page outlines our progress so far.
-
A new toolkit to support babies, children and young people in healthcare access high quality health play services was launched at UCLH last week with UCLH chief nurse Vanessa Sweeney welcoming visitors from NHS England and the play charity Starlight.
-
As an organisation, UCLH needs to minimise the environmental impact of our buildings and the energy they use and maximise our use of any technology available to support these changes. This page outlines our progress to date.
-
The first ever treatment for the rare neurodegenerative disease Friedreich’s ataxia – for which UCLH and UCL led the UK trial – has been approved for use in the UK by the medicines’ regulator.
File results
-
FOI/2023/0236 - Proton Beam Therapy Centre
-
FOI/2023/0457 - Psychiatric/ behavioural problems linked to psychiatric disorders use of force policies
-
FOI/2023/0462 - Patients to hotels
-
FOI/2024/0481 - Maternity unit closed to new admissions 2018-2023
-
FOI/2023/0481 - Closure of maternity unit to new admissions 2018/23
-
FOI/2023/0484 - Babies diagnosed with Tongue Tie
-
FOI/2023/0486 - Mastectomy reconstruction
-
FOI/2023/0497 - List of all laboratories within Pathology
-
FOI/2023/0513 - Radiology equipment inventory
-
FOI/2023/0515 - Visitor policy in response to Covid-19